Translational Session
Recent Trials in Vascular Calcification and Kidney Stone Diseases
October 22, 2026 | 02:00 PM - 04:00 PM
Location: Room 405, Convention Center
Session Description
Robust clinical trial evidence to guide treatments for preventing kidney stone diseases and pathological vascular calcification has been relatively sparse. Several important studies have helped fill this gap in recent years. This session describes a large, randomized study of kidney stones, groundbreaking treatments for primary hyperoxaluria type 1, and rigorous studies assessing the effects of vitamin K on vascular calcification and treatments for hyperphosphatemia in CKD progression.
Learning Objective(s)
- Describe known therapeutic targets in kidney stone diseases and hyperphosphatemia
- List evidence for and against known strategies for kidney stone diseases and hyperphosphatemia
- Describe possible mineral metabolism treatment targets on the horizon for kidney stone diseases
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
- Pharmacology
Moderators
Presentations
- Strategies to Increase Water Intake and Effects on Kidney Stone Events
02:00 PM - 02:30 PM
- Vitamin K in Vascular Calcification, Calciphylaxis, and Renal Osteodystrophy
02:30 PM - 03:00 PM
- siRNAs to Correct Hyperoxaluria
03:00 PM - 03:30 PM
- Clinical Trials of Dietary Phosphate Restriction and CKD-MBD
03:30 PM - 04:00 PM